Analyst Recommendations

Cantor Fitzgerald analyst issues NEUTRAL recommendation for CVS on August 8, 2024 07:50AM ET. The previous analyst recommendation was Neutral.CVS was trading at $56.47 at issue of the...

August 8, 2024   CVS -3.46%

Evercore ISI analyst issues NEUTRAL recommendation for CAG on August 8, 2024 07:50AM ET. The previous analyst recommendation was Neutral.CAG was trading at $29.78 at issue of the...

August 8, 2024   CAG -2.33%

Wells Fargo analyst issues EQUAL-WEIGHT recommendation for CAG on August 8, 2024 07:50AM ET. The previous analyst recommendation was Equal-Weight.CAG was trading at $29.78 at issue of the...

August 8, 2024   CAG -2.33%

Oppenheimer analyst issues OUTPERFORM recommendation for APP on August 8, 2024 07:43AM ET. The previous analyst recommendation was Outperform.APP was trading at $67.19 at issue of the analyst...

August 8, 2024   APP -6.13%

Oppenheimer analyst issues OUTPERFORM recommendation for CEVA on August 8, 2024 07:44AM ET. The previous analyst recommendation was Outperform.CEVA was trading at $19.44 at issue of the analyst...

August 8, 2024   CEVA 3.14%

Oppenheimer analyst issues OUTPERFORM recommendation for ORA on August 8, 2024 07:49AM ET. The previous analyst recommendation was Outperform.ORA was trading at $72.49 at issue of the analyst...

August 8, 2024   ORA 2.09%

Needham analyst issues UNDERPERFORM recommendation for DUOL on August 8, 2024 08:01AM ET. The previous analyst recommendation was Underperform.DUOL was trading at $161.4 at issue of the analyst...

August 8, 2024   DUOL -2.58%

UBS analyst issues BUY recommendation for UPWK on August 8, 2024 08:00AM ET. The previous analyst recommendation was Buy.UPWK was trading at $10.46 at issue of the analyst...

August 8, 2024   UPWK -1.14%

Oppenheimer analyst issues OUTPERFORM recommendation for RXO on August 8, 2024 07:51AM ET. The previous analyst recommendation was Outperform.RXO was trading at $29.11 at issue of the analyst...

August 8, 2024   RXO -3.24%

Oppenheimer analyst issues OUTPERFORM recommendation for ROK on August 8, 2024 07:50AM ET. The previous analyst recommendation was Outperform.ROK was trading at $249.16 at issue of the analyst...

August 8, 2024   ROK -1.41%